Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2323]
News [5452]
Articles [134]
Editorials [4]
Conferences [158]
elearning [13]
T cells expressing two additional receptors (TETARs) for the use in a multiple...
Dr Gerold Schuler - Universitätsklinikum, Erlangen, Germany
T cells expressing two additional receptors (TETARs) for the use in a multiple- hit immunotherapy ( Dr Gerold Schuler - Universitätsklinikum, Erlangen, Germany )
4 Apr 2016
Immunotherapy and personalised medicine in review
Prof Paul Sondel - University of Wisconsin, Madison, USA
Immunotherapy and personalised medicine in review ( Prof Paul Sondel - University of Wisconsin, Madison, USA )
4 Apr 2016
Treating childhood brainstem cancer using nanotechnology
Dr Dannis Van Vuurden - VU University Medical Center, Amsterdam, The Netherlands
Treating childhood brainstem cancer using nanotechnology ( Dr Dannis Van Vuurden - VU University Medical Center, Amsterdam, The Netherlands )
8 Feb 2016
Molecular drug imaging to guide brain cancer therapy
Dr Dannis Van Vuurden - VU University Medical Center, Amsterdam, The Netherlands
Molecular drug imaging to guide brain cancer therapy ( Dr Dannis Van Vuurden - VU University Medical Center, Amsterdam, The Netherlands )
8 Feb 2016
Complementary drug delivery techniques for interstitial administration
Dr Ruman Rahman - University of Nottingham, Nottingham, UK
Complementary drug delivery techniques for interstitial administration ( Dr Ruman Rahman - University of Nottingham, Nottingham, UK )
4 Feb 2016
Editor's choice for January 2016
Prof Gordon McVie - ecancer Editor
Editor's choice for January 2016 ( Prof Gordon McVie - ecancer Editor )
2 Feb 2016
Advanced prostate cancer overview: Expert discussion
Dr Heather Payne, Prof Romano Danesi, Prof Luis da Costa, Prof Peter Mulders
Advanced prostate cancer overview: Expert discussion ( Dr Heather Payne, Prof Romano Danesi, Prof Luis da Costa, Prof Peter Mulders )
27 Jan 2016
Best of ASCO GU 2016 prostate cancer data
Prof Noel Clarke, Dr Heather Payne, Prof Peter Iverson
Best of ASCO GU 2016 prostate cancer data ( Prof Noel Clarke, Dr Heather Payne, Prof Peter Iverson )
8 Jan 2016
Subgroup analyses of METEOR; randomized phase III trial of cabozantinib vs...
Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France
Subgroup analyses of METEOR; randomized phase III trial of cabozantinib vs everolimus for RCC ( Prof Bernard Escudier - Institut Gustave-Roussy, Paris, France )
8 Jan 2016
Discontinuing VEGF-targeted therapy for progression or toxicity affects...
Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA
Discontinuing VEGF-targeted therapy for progression or toxicity affects outcomes of second-line therapies in mRCC ( Dr Guillermo de Velasco - Dana-Farber Cancer Institute, Boston, USA )
8 Jan 2016
Molecular genetics of testicular cancer: What does the clinician need to know?
Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA
Molecular genetics of testicular cancer: What does the clinician need to know? ( Dr Katherine Nathanson - University of Pennsylvania, Philadelphia, USA )
8 Jan 2016
New treatment options in metastatic prostate cancer
Dr Neal Shore and Dr Axel Merseburger
New treatment options in metastatic prostate cancer ( Dr Neal Shore and Dr Axel Merseburger )
8 Jan 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation